Opportunity Information: Apply for CDC RFA GH12 1238
Apply for CDC RFA GH12 1238
- The Centers for Disease Control and Prevention in the health sector is offering a public funding opportunity titled "Expanding Comprehensive HIV Prevention Programs for People Who Inject Drugs and People Who Use Drugs in the United Republic of Tanzania under the Presidents Emergency Plan for AIDS Relief (PEPFAR" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.067 Global AIDS.
- This funding opportunity was created on May 7, 2012 and posted on Mar 23, 2012.
- Applicants must submit their applications by May 14, 2012. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The funding agency has allocated a total of $7,500,000.00 to eligible and selected applicants.
- Each selected applicant is eligible to receive up to $1,500,000.00 in funding.
- The number of recipients for this funding is limited to 1 candidate(s).
- Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).
- Expanding Comprehensive HIV Prevention Programs for People Who Inject Drugs and People Who Use Drugs in the United Republic of Tanzania under the President s Emergency Plan for AIDS Relief (PEPFAR)
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
This funding opportunity, issued by the U.S. Centers for Disease Control and Prevention (CDC) under PEPFAR, is focused on expanding comprehensive HIV prevention services for people who inject drugs and people who use drugs in the United Republic of Tanzania. The intent is to strengthen and broaden evidence-based prevention programming for a population that often faces a disproportionately high risk of HIV infection and significant barriers to accessing health services, including stigma, discrimination, and limited availability of tailored prevention and care. The award is structured as a cooperative agreement, which typically means CDC would expect to have substantial involvement in the planning, implementation, and monitoring of the funded activities, rather than operating as a hands-off funder.
The opportunity is identified as Funding Opportunity Number CDC-RFA-GH12-1238 and falls under the discretionary funding category, with the activity area listed as health. The CFDA number provided is 93.067 (Global AIDS), aligning the work with U.S. global HIV/AIDS priorities. The program’s title makes clear that it supports PEPFAR’s broader goals of reducing new HIV infections, improving access to prevention and treatment, and addressing key populations whose needs are frequently underserved in generalized public health responses. In practical terms, this kind of initiative generally emphasizes a combination prevention approach, meaning multiple complementary interventions delivered together to reduce risk and improve health outcomes.
Funding details show an estimated total funding amount of $7,500,000, with an award ceiling of $1,500,000, and an expectation of one award. This suggests a single implementing partner would likely be responsible for coordinating a sizable package of activities, potentially across multiple sites or regions, and for integrating services with existing national and PEPFAR-supported programs. The absence of a cost-sharing or matching requirement indicates applicants would not be required to contribute their own funds as a condition of eligibility, which can lower the barrier to participation for organizations with strong technical capacity but limited unrestricted resources.
The timeline provided indicates the opportunity was posted on March 23, 2012, created on May 7, 2012, with an original closing date of May 7, 2012, later extended to May 14, 2012. The archive date is June 13, 2012, meaning it is no longer active, but the details still describe what CDC was seeking to fund at that time. Eligible applicants are listed broadly as “Others,†with a note to consult the full announcement’s eligibility section for specifics, which typically clarifies whether eligibility includes non-governmental organizations, universities, non-profits, international organizations, or local entities registered in Tanzania, and may set conditions related to demonstrated experience, financial systems, or in-country operational capacity.
Although the brief source text does not list specific required program components, the stated focus on “expanding comprehensive HIV prevention programs†for people who inject and use drugs generally implies a set of interventions that public health agencies commonly support for these groups. These often include outreach and peer-based education, HIV testing services and linkage to care, condom distribution and sexual risk reduction counseling, and risk-reduction services tailored to drug use. For people who inject drugs, comprehensive prevention frequently includes harm reduction elements such as sterile needle and syringe access where permitted, safe injection education, overdose prevention education, and referral pathways to substance use treatment services. In many PEPFAR contexts, additional emphasis is placed on strengthening referral networks, improving retention in services, integrating with sexually transmitted infection screening and treatment, and ensuring that services are delivered in a way that is acceptable, confidential, and responsive to the lived realities of the target population.
Because it is a cooperative agreement, the implementing partner would typically be expected to work closely with CDC and relevant Tanzanian stakeholders to align with national HIV strategies and policies, coordinate with other PEPFAR implementing partners, and support data-driven program management. This usually includes establishing or strengthening monitoring and evaluation systems, reporting on key indicators, using program data to refine service delivery, and demonstrating that services are reaching the intended populations. Many CDC-funded HIV prevention programs also emphasize capacity building, meaning training and mentoring of local health workers, community organizations, and peer outreach teams, alongside strengthening management, logistics, and quality assurance processes to sustain services over time.
The administering agency is explicitly the CDC. For applicants who had trouble accessing the full announcement, the contact listed is CDC’s Procurement and Grant Office (PGO), with the email pgotim@cdc.gov and phone number 770-488-2700. This contact information indicates where prospective applicants could request assistance with the application package, submission requirements, or technical access issues. Overall, the opportunity reflects a targeted PEPFAR investment aimed at scaling up proven HIV prevention approaches for people who inject drugs and people who use drugs in Tanzania, using a single award model to drive coordinated implementation and measurable prevention impact.
Frequently Asked Questions (FAQs)
1. What is this funding opportunity about?
This CDC funding opportunity (under PEPFAR) is focused on expanding comprehensive HIV prevention services for people who inject drugs and people who use drugs in the United Republic of Tanzania. The overall intent is to strengthen and broaden evidence-based prevention programming for a population that often faces high HIV risk and major barriers to care, including stigma, discrimination, and limited availability of tailored services.
2. Who is issuing and administering this opportunity?
The administering agency is the U.S. Centers for Disease Control and Prevention (CDC). The opportunity is issued under PEPFAR as part of U.S. global HIV/AIDS efforts.
3. What is the Funding Opportunity Number (FON)?
The Funding Opportunity Number is CDC-RFA-GH12-1238.
4. What is the CFDA number and what does it indicate?
The CFDA number listed is 93.067 (Global AIDS). This indicates the opportunity aligns with U.S. global HIV/AIDS priorities and programming.
5. What is the activity area and funding category?
The activity area is health, and the funding category is discretionary.
6. What type of award is this?
This award is structured as a cooperative agreement. In practice, this typically means CDC expects substantial involvement in planning, implementation, and monitoring of activities, rather than operating as a hands-off funder.
7. What does CDC "substantial involvement" usually mean in a cooperative agreement?
Based on the description provided, substantial involvement generally means the recipient would work closely with CDC on aligning activities with national strategies and PEPFAR priorities, coordinating with stakeholders, and supporting data-driven program management (including monitoring, evaluation, and reporting on key indicators).
8. What is the estimated total funding amount?
The estimated total funding amount is $7,500,000.
9. What is the award ceiling?
The award ceiling is $1,500,000.
10. How many awards does CDC expect to make?
The opportunity indicates an expectation of one award.
11. What does "one award" suggest about implementation?
With one expected award and a sizable funding profile, a single implementing partner would likely be responsible for coordinating a large package of activities, potentially across multiple sites or regions, and integrating services with national and PEPFAR-supported programs.
12. Is cost sharing or matching required?
No. The opportunity states there is no cost-sharing or matching requirement, meaning applicants are not required to contribute their own funds as a condition of eligibility.
13. Where will the program activities take place?
The geographic focus is the United Republic of Tanzania.
14. Who is the primary population of focus?
The program is focused on people who inject drugs and people who use drugs, who are described as facing disproportionately high HIV risk and significant barriers to accessing health services.
15. What kinds of HIV prevention activities are implied by "comprehensive prevention" for people who inject or use drugs?
While the brief description does not list required components, it notes that comprehensive prevention for these groups commonly includes outreach and peer-based education, HIV testing services and linkage to care, condom distribution and sexual risk-reduction counseling, and risk-reduction services tailored to drug use.
16. Are harm reduction services included or suggested?
The description indicates that for people who inject drugs, comprehensive prevention frequently includes harm reduction elements such as sterile needle and syringe access where permitted, safe injection education, overdose prevention education, and referral pathways to substance use treatment services.
17. Does the opportunity emphasize linking people to HIV care and other services?
Yes. The description references HIV testing and linkage to care, strengthening referral networks, improving retention in services, and integrating with other services such as sexually transmitted infection screening and treatment.
18. Are confidentiality and stigma-reduction considerations addressed?
Yes. The opportunity notes that target populations face stigma and discrimination and emphasizes delivering services in ways that are acceptable, confidential, and responsive to the lived realities of the target population.
19. Does this opportunity mention monitoring and evaluation expectations?
Yes. The description suggests establishing or strengthening monitoring and evaluation systems, reporting on key indicators, using program data to refine service delivery, and demonstrating that services are reaching intended populations.
20. Does the opportunity include capacity building?
Yes. It notes that many CDC-funded HIV prevention programs emphasize capacity building, such as training and mentoring local health workers, community organizations, and peer outreach teams, along with strengthening management, logistics, and quality assurance processes to sustain services over time.
21. Who is eligible to apply?
Eligible applicants are listed broadly as "Others," with a note to consult the full announcement's eligibility section for specifics. The summary indicates that the full eligibility section typically clarifies which entity types may apply (for example, non-governmental organizations, universities, non-profits, international organizations, or local entities registered in Tanzania) and may include conditions related to experience, financial systems, or in-country operational capacity.
22. Is this funding opportunity still active?
No. The archive date is June 13, 2012, and the closing date has passed. The details describe what CDC was seeking to fund at that time.
23. When was the opportunity posted and when did it close?
The opportunity was posted on March 23, 2012. It shows an original closing date of May 7, 2012, later extended to May 14, 2012. The record also notes it was created on May 7, 2012.
24. Who should be contacted for application package or submission issues?
The contact listed is CDC's Procurement and Grant Office (PGO). Email: pgotim@cdc.gov. Phone: 770-488-2700.
25. How does this opportunity fit into PEPFAR goals?
The description indicates the initiative supports PEPFAR goals by targeting reductions in new HIV infections, improving access to prevention and treatment, and addressing key populations whose needs are frequently underserved in generalized public health responses.
Browse more opportunities from the same category: Health
Next opportunity: Cooperative Ecosystem Studies Unit, Californian CESU
Previous opportunity: Increasing the Supply of Safe Blood for Transfusions in the United Republic of Tanzania and Zanzibar through Blood Collection, Donor Mobilization, and Technical Assistance under the Presidents Emergency Plan for AIDS Relief (PEPFAR)
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for CDC RFA GH12 1238
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (CDC RFA GH12 1238) also looked into and applied for these:
| Funding Opportunity |
|---|
| Strengthening Civil Society Organizations to support vulnerable populations in Rwanda Apply for APS 696 12 00001 Funding Number: APS 696 12 00001 Agency: Rwanda USAID Kigali Category: Health Funding Amount: $4,500,000 |
| Drug Free Communities Mentoring Program Apply for SP 12 002 Funding Number: SP 12 002 Agency: Substance Abuse Mental Health Services Adminis. Category: Health Funding Amount: $75,000 |
| MCH Pediatric Research Network Program Apply for HRSA 12 019 Funding Number: HRSA 12 019 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Nurse Faculty Loan Program (NFLP) Apply for HRSA 12 064 Funding Number: HRSA 12 064 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Strengthening the quality and scope of undergraduate and postgraduate medical and public health training programs at the University of Zambia, School of Medicine in the Republic of Zambia under the Presidents Emergency Plan for AIDS Relief (PEPFAR Apply for CDC RFA GH12 1241 Funding Number: CDC RFA GH12 1241 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $2,000,000 |
| Building a Medical Home for Multiply Diagnosed HIV positive Homeless Populations Demonstration Sites Apply for HRSA 12 100 Funding Number: HRSA 12 100 Agency: Health Resources and Services Administration Category: Health Funding Amount: $300,000 |
| Building a Medical Home for HIV positive Multiply Diagnosed Homeless Populations Initiative Evaluation and Technical Assistance Center Apply for HRSA 12 104 Funding Number: HRSA 12 104 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Partnerships for Sustainable Research and Dissemination of Evidence based Medicine (R24) Apply for RFA HS 12 005 Funding Number: RFA HS 12 005 Agency: Agency for Health Care Research and Quality Category: Health Funding Amount: $300,000 |
| Development and Translation of Medical Technologies to Reduce Health Disparities (R43/R44) Apply for RFA EB 12 001 Funding Number: RFA EB 12 001 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Strengthening Blood Donor Associations in Mozambique under the Presidents Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH12 1223 Funding Number: CDC RFA GH12 1223 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $100,000 |
| Public Health Conference Support for Birth Defects and Developmental Disabilities Apply for CDC RFA DD12 1203 Funding Number: CDC RFA DD12 1203 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $100,000 |
| Building the capacity of the National AIDS Control Program of the Ministry of Health to Expand Coordinated HIV Prevention, Care, Treatment, and Strategic Information Programs in the United Republic of Tanzania under the Presidents Emergency Plan for Apply for CDC RFA GH12 1240 Funding Number: CDC RFA GH12 1240 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $5,000,000 |
| Partnerships for Interventions to Treat Chronic, Persistent and Latent Infections (R21/R33) Apply for RFA AI 12 020 Funding Number: RFA AI 12 020 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| NIDCR Small Research Grants for Oral Health Data Analysis and Statistical Methodology Development (R03) Apply for PAR 12 120 Funding Number: PAR 12 120 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Child Survival Health Grants Program Fiscal Year 2012 Apply for RFA OAA 12 000008 Funding Number: RFA OAA 12 000008 Agency: Agency for International Development Category: Health Funding Amount: $13,500,000 |
| Initiative to Reduce Avoidable Hospitalizations among Nursing Facility Residents Apply for CMS 1E1 12 002 Funding Number: CMS 1E1 12 002 Agency: Centers for Medicare Medicaid Services Category: Health Funding Amount: $30,000,000 |
| Studies in Parkinsons Disease Biomarkers Discovery (U01) Apply for RFA NS 12 011 Funding Number: RFA NS 12 011 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Exploratory Laboratory and Analysis Projects in Parkinsons Disease Biomarkers (U18) Apply for RFA NS 12 010 Funding Number: RFA NS 12 010 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| NIDCD Phase I/II/III Clinical Trials in Communication Disorders (U01) Apply for PAR 12 123 Funding Number: PAR 12 123 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NIDCD Planning Grant for Phase III Clinical Trials in Communication Disorders (U34) Apply for PAR 12 124 Funding Number: PAR 12 124 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "CDC RFA GH12 1238", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.